Dialogues in Clinical Neuroscience · 2000 · 225 citations · 119 references
MedicineNeurosciencePharmacologyMemoryNeurodegenerationNeuropharmacologyCognitive ImpairmentMolecular Basis Of NeurodegenerationNeurodegeneration MechanismsNeurodegenerative DiseasesNeurodegenerative DisordersNeuroprotectionAge-related Neurodegenerative MechanismsAnimal Model PharmacologyExcitatory Pyramidal NeuronsNmda Receptor FunctionNmda Receptor PharmacologyNmda ReceptorsOxidative Stress In NeurodegenerationOxidative Stress Injury
An increasing level of N-methyl-D-aspartate (NMDA) receptor hypofunction within the brain is associated with memory and learning impairments, with psychosis, and ultimately with excitotoxic brain injury. As the brain ages, the NMDA receptor system becomes progressively hypofunctional, contributing to decreases in memory and learning performance. In those individuals destined to develop Alzheimer's disease, other abnormalities (eg, amyloidopathy and oxidative stress) interact to increase the NMDA receptor hypofunction (NRHypo) burden. In these vulnerable individuals, the brain then enters into a severe and persistent NRHypo state, which can lead to widespread neurodegeneration with accompanying mental symptoms and further cognitive deterioration. If the hypotheses described herein prove correct, treatment implications may be considerable. Pharmacological methods for preventing the overstimulation of vulnerable corticolimbic pyramidal neurons developed in an animal model may be applicable to the prevention and treatment of Alzheimer's disease.
119
Glutamate neurotoxicity and diseases of the nervous system
Dennis W. Choi · Neuron · 1988 · 8K citations
Heteromeric NMDA Receptors: Molecular and Functional Distinction of Subtypes
Hannah Monyer, Rolf Sprengel, Ralf Schoepfer et al. · Science · 1992 · 2.5K citations